Strategic partnerships CHOU2 PHARMA actively pursues collaborations with research and industry organizations, such as Ethos Discovery, to advance veterinary cannabinoid science and potentially co develop or validate new formulations. Use this to position partner outreach and joint study opportunities with veterinary researchers, veterinary clinics, and pet health networks.

Expansion momentum Recent leadership changes and INAD filings indicate a deliberate pipeline expansion into new cannabinoid-based companion animal drugs. Target outreach to veterinary distributors, specialty clinics, and pet product retailers seeking innovative, science‑driven therapeutic options.

Early market traction With partnerships and a distribution deal in place at PetSmart and a multi-location reach, CHOU2 PHARMA has established a viable go‑to‑market presence despite a small team and revenue under one million. Leverage these credentials to approach retailers, clinics, and dosing guidance platforms that value vetted, purified formulations.

Purity and efficacy The Cannolation Purification System emphasizes ingredient purity, dosage accuracy, safety, and effectiveness. This can be a strong differentiator in sales pitches to veterinarians and pet owners seeking reliable, evidence‑based cannabinoid therapies and professional education programs.

Tech-enabled outreach Utilize CHOU2 PHARMA’s tech stack (WooCommerce, Mailchimp, Klaviyo, Trustpilot, AWS) to craft targeted digital campaigns, nurture veterinary leads, and gather testimonials. Propose collaboration on education campaigns, digital trials, and data collection to accelerate adoption and sales.